October 16, 2023- B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced at the Association for Vascular Access (AVA) Scientific Meeting its expanded focus on addressing health inequities in vascular access and continued commitment to improve patients’ experiences with peripheral intravenous (IV) therapy through a multifaceted approach focused on education, training and advancing standards of care.
Peripheral vascular access is a critical component of patient care and the most common invasive procedure performed in healthcare,with more than 300 million peripheral intravenous catheters (PIVC) sold annually in the United States. However, the experience of receiving an IV is not the same for all patients. In a study of over 100,000 emergency department (ED) patients, the rate of difficult intravenous access (DIVA) was 58% higher for Black patients compared to White patients.
The Peripheral Advantage Program is designed to optimize clinical skills and product performance for better clinical outcomes. Real-time data is collected throughout the program to provide baseline and ongoing insights and analytics to healthcare leadership to help gauge the program’s impact on areas including patient satisfaction, first-stick success, PIVC catheter dwell time and overall cost containment.
The program helps to standardize and improve PIVC insertion best practices by equipping clinicians with the training, tools and data-informed insights they need to address disparities in PIVC care and elevate the standard of care.